{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:01:17Z","timestamp":1790733677489,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,12,13]],"date-time":"2007-12-13T00:00:00Z","timestamp":1197504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s11373-007-9224-9","type":"journal-article","created":{"date-parts":[[2007,12,12]],"date-time":"2007-12-12T06:58:01Z","timestamp":1197442681000},"page":"205-213","source":"Crossref","is-referenced-by-count":3,"title":["Human uridine-cytidine kinase phosphorylation of ribavirin: a convenient method for activation of ribavirin for conjugation to proteins"],"prefix":"10.1186","volume":"15","author":[{"given":"Lucija","family":"Virovic Jukic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Duvnjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine H.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,13]]},"reference":[{"key":"9224_CR1","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1021\/jm00281a014","volume":"15","author":"JT Witkowski","year":"1972","unstructured":"Witkowski JT, Robins RK, Sidewell R, Simol L (1972) Design, synthesis and broad spectrum antiviral activity of 1-\u03b2-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. J Med Chem 15:1150\u20131154","journal-title":"J Med Chem"},{"key":"9224_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","volume":"339","author":"JG McHutchison","year":"1998","unstructured":"McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK (1998) Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339:1485\u20131492","journal-title":"N Engl J Med"},{"key":"9224_CR3","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","volume":"352","author":"T Poynard","year":"1998","unstructured":"Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J (1998) Randomised trial of interferon alpha-2b plus ribavirin for 48\u00a0weeks or for 24\u00a0weeks versus interferon alpha-2b plus placebo for 48\u00a0weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 352:1426\u20131432","journal-title":"Lancet"},{"key":"9224_CR4","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1128\/AAC.43.11.2716","volume":"43","author":"M Homma","year":"1999","unstructured":"Homma M, Jayewardene AL, Gambertoglio J, Aweeka F (1999) High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytes. Antimicrob Agents Chemother 43:2716\u20132719","journal-title":"Antimicrob Agents Chemother"},{"key":"9224_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1517\/17425247.2.4.707","volume":"2","author":"L Virovic","year":"2005","unstructured":"Virovic L, Wu CH, Konishi M, Wu GY (2005) Novel delivery methods for treatment of viral hepatitis: an update. Expert Opin Drug Deliv 2:707\u2013717","journal-title":"Expert Opin Drug Deliv"},{"key":"9224_CR6","doi-asserted-by":"publisher","first-page":"d717","DOI":"10.2741\/wu2","volume":"7","author":"J Wu","year":"2002","unstructured":"Wu J, Nantz MH, Zern MA (2002) Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front Biosci 7:d717\u2013d725","journal-title":"Front Biosci"},{"key":"9224_CR7","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1016\/S0021-9258(18)61209-8","volume":"262","author":"GY Wu","year":"1987","unstructured":"Wu GY, Wu CH (1987) Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 262:4429\u20134432","journal-title":"J Biol Chem"},{"key":"9224_CR8","doi-asserted-by":"crossref","first-page":"14338","DOI":"10.1016\/S0021-9258(18)98689-8","volume":"266","author":"GY Wu","year":"1991","unstructured":"Wu GY, Wilson JM, Shalaby F, Grossman M, Shafritz DA, Wu CH (1991) Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. J Biol Chem 266:14338\u201314342","journal-title":"J Biol Chem"},{"key":"9224_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0166-0934(93)90181-P","volume":"42","author":"M Reinis","year":"1993","unstructured":"Reinis M, Damkova M, Korec E (1993) Receptor-mediated transport of oligodeoxynucleotides into hepatic cells. J Virol Methods 42:99\u2013105","journal-title":"J Virol Methods"},{"key":"9224_CR10","doi-asserted-by":"crossref","first-page":"12436","DOI":"10.1016\/S0021-9258(18)42295-8","volume":"267","author":"GY Wu","year":"1992","unstructured":"Wu GY, Wu CH (1992) Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. J Biol Chem 267:12436\u201312439","journal-title":"J Biol Chem"},{"key":"9224_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2893.1995.tb00041.x","volume":"2","author":"RM Bartholomew","year":"1995","unstructured":"Bartholomew RM, Carmichael EP, Findeis MA, Wu CH, Wu GY (1995) Targeted delivery of antisense DNA in woodchuck hepatitis virus-infected woodchucks. J Viral Hepat 2:273\u2013278","journal-title":"J Viral Hepat"},{"key":"9224_CR12","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/S0016-5085(98)70437-8","volume":"114","author":"CH Wu","year":"1998","unstructured":"Wu CH, Wu GY (1998) Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines. Gastroenterology 114:1304\u20131312","journal-title":"Gastroenterology"},{"key":"9224_CR13","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.59.5.1181","volume":"59","author":"AR Rompay Van","year":"2001","unstructured":"Van Rompay AR, Norda A, Linden K, Johansson M, Karlsson A (2001) Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases. Mol Pharmacol 59:1181\u20131186","journal-title":"Mol Pharmacol"},{"key":"9224_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pharmthera.2003.07.001","volume":"100","author":"AR Rompay Van","year":"2003","unstructured":"Van Rompay AR, Johansson M, Karlsson A (2003) Substrate specificity of antiviral and anticancer nucleoside analogues by human deoxyribonucleoside kinases and ribonucleoside kinases. Pharmacol Ther 100:119\u2013139","journal-title":"Pharmacol Ther"},{"key":"9224_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0163-7258(00)00048-6","volume":"87","author":"AR Rompay Van","year":"2000","unstructured":"Van Rompay AR, Johansson M, Karlsson A (2000) Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases. Pharmacol Ther 87:189\u2013198","journal-title":"Pharmacol Ther"},{"key":"9224_CR16","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1124\/mol.56.3.562","volume":"56","author":"AR Rompay Van","year":"1999","unstructured":"Van Rompay AR, Johansson M, Karlsson A (1999) Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase: molecular characterization of the human enzyme. Mol Pharmacol 56:562\u2013569","journal-title":"Mol Pharmacol"},{"key":"9224_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0021-9673(01)85696-X","volume":"71","author":"J Lust","year":"1972","unstructured":"Lust J, Sahud MA (1972) Contributions of anion-exchange thin-layer chromatography to the study of free nucleotides in tissues. J Chromatogr 71:127\u2013133","journal-title":"J Chromatogr"},{"key":"9224_CR18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-4165(66)90336-9","volume":"124","author":"PH Whitehead","year":"1966","unstructured":"Whitehead PH, Sammons HG (1966) A simple technique for the isolation of orosomucoid from normal and pathological sera. Biochim Biophys Acta 124:209\u2013211","journal-title":"Biochim Biophys Acta"},{"key":"9224_CR19","first-page":"99","volume":"41","author":"G Ashwell","year":"1974","unstructured":"Ashwell G, Morell AG (1974) The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol 41:99\u2013133","journal-title":"Adv Enzymol"},{"key":"9224_CR20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj1040361","volume":"104","author":"K Schmid","year":"1967","unstructured":"Schmid K, Polis A, Hunziker K, Fricke R, Yayoshi M (1967) Partial characterization of the sialic acid-free forms of alpha-1-acid glycoprotein from human plasma. Biochem J 104:361\u2013368","journal-title":"Biochem J"},{"key":"9224_CR21","doi-asserted-by":"crossref","first-page":"14621","DOI":"10.1016\/S0021-9258(18)68081-0","volume":"263","author":"GY Wu","year":"1988","unstructured":"Wu GY, Wu CH (1988) Receptor-mediated gene delivery and expression in vivo. J Biol Chem 263:14621\u201314624","journal-title":"J Biol Chem"},{"key":"9224_CR22","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.1016\/S0021-9258(17)44450-4","volume":"258","author":"JA Oka","year":"1983","unstructured":"Oka JA, Weigel PH (1983) Recycling of the asialoglycoprotein receptor in isolated rat hepatocytes. Dissociation of internalized ligand from receptor occurs in two kinetically and thermally distinguishable compartments. J Biol Chem 258:10253\u201310262","journal-title":"J Biol Chem"},{"key":"9224_CR23","doi-asserted-by":"publisher","first-page":"6513","DOI":"10.1093\/nar\/11.18.6513","volume":"11","author":"BCF Chu","year":"1983","unstructured":"Chu BCF, Wahl GM, Orgel LE (1983) Derivatization of unprotected polynucleotides. Nucleic Acids Res 11:6513\u20136529","journal-title":"Nucleic Acids Res"},{"key":"9224_CR24","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/sj.bjp.0701775","volume":"123","author":"SM Jarvis","year":"1998","unstructured":"Jarvis SM, Thorn JA, Glue P (1998) Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters. Br J Pharmacol 123:1587\u20131592","journal-title":"Br J Pharmacol"},{"key":"9224_CR25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00001432-200112000-00015","volume":"14","author":"CE Cameron","year":"2001","unstructured":"Cameron CE, Castro C (2001) The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase. Curr Opin Infect Dis 14:757\u2013764","journal-title":"Curr Opin Infect Dis"},{"key":"9224_CR26","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1073\/pnas.75.7.3042","volume":"75","author":"RC Willis","year":"1978","unstructured":"Willis RC, Carson DA, Seegmiller JE (1978) Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line. Proc Natl Acad Sci USA 75:3042\u20133044","journal-title":"Proc Natl Acad Sci USA"},{"key":"9224_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0020-711X(90)90140-X","volume":"22","author":"T Page","year":"1990","unstructured":"Page T, Connor JD (1990) The metabolism of ribavirin in erythrocytes and nucleated cells. Int J Biochem 22:379\u2013383","journal-title":"Int J Biochem"},{"key":"9224_CR28","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1124\/mol.63.3.538","volume":"63","author":"S Gallois-Montbrun","year":"2003","unstructured":"Gallois-Montbrun S, Chen Y, Dutartre H, Sophys M, Morera S, Guerreiro C, Schneider B, Mulard L, Janin J, Veron M, Deville-Bonne D, Canard B (2003) Structural analysis of the activation of ribavirin analogs by NDP kinase: comparison with other ribavirin targets. Mol Pharmacol 63:538\u2013546","journal-title":"Mol Pharmacol"},{"key":"9224_CR29","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/S0021-9258(18)95981-8","volume":"242","author":"DG Hoare","year":"1967","unstructured":"Hoare DG, Koshland DE (1967) A method for the quantitative modification and estimation of carboxylic acid groups in proteins. J Biol Chem 242:2447\u20132453","journal-title":"J Biol Chem"},{"key":"9224_CR30","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1093\/nar\/16.9.3721","volume":"16","author":"NG Dolinnaya","year":"1988","unstructured":"Dolinnaya NG, Sokolova NI, Gryaznova OI, Shabarova ZA (1988) Site-directed modification of DNA duplexes by chemical ligation. Nucleic Acids Res 16:3721\u20133738","journal-title":"Nucleic Acids Res"},{"key":"9224_CR31","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1093\/nar\/14.14.5591","volume":"14","author":"BCF Chu","year":"1986","unstructured":"Chu BCF, Kramer FR, Orgel LE (1986) Synthesis of an amplifiable reporter RNA for bioassays. Nucleic Acids Res 14:5591\u20135603","journal-title":"Nucleic Acids Res"},{"key":"9224_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0092-8674(80)90116-6","volume":"21","author":"DA Wall","year":"1980","unstructured":"Wall DA, Wilson G, Hubbard AL (1980) The galactose-specific recognition system of mammalian liver: the route of ligand internalization in rat hepatocytes. Cell 21:79\u201393","journal-title":"Cell"},{"key":"9224_CR33","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/clinids\/12.6.1139","volume":"12","author":"JL Patterson","year":"1990","unstructured":"Patterson JL, Fernandez-Larsson R (1990) Molecular mechanisms of action of ribavirin. Rev Infect Dis 12:1139\u20131146","journal-title":"Rev Infect Dis"},{"key":"9224_CR34","doi-asserted-by":"publisher","first-page":"46094","DOI":"10.1074\/jbc.C100349200","volume":"276","author":"D Maag","year":"2001","unstructured":"Maag D, Castro C, Hong Z, Cameron CE (2001) Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. J Biol Chem 276:46094\u201346098","journal-title":"J Biol Chem"},{"key":"9224_CR35","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1073\/pnas.70.4.1174","volume":"70","author":"DG Streeter","year":"1973","unstructured":"Streeter DG, Witkowski JT, Khare GP, Sidwell RW, Bauer RJ, Robins RK, Simon LN (1973) Mechanism of action of 1-\u03b2-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc Natl Acad Sci USA 70:1174\u20131178","journal-title":"Proc Natl Acad Sci USA"},{"key":"9224_CR36","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/0006-2952(77)90246-5","volume":"26","author":"WE Muller","year":"1977","unstructured":"Muller WE, Maidhof A, Taschner H, Zahn RK (1977) Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent. Biochem Pharmacol 26:1971\u20131075","journal-title":"Biochem Pharmacol"},{"key":"9224_CR37","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1128\/AAC.11.6.946","volume":"11","author":"B Eriksson","year":"1977","unstructured":"Eriksson B, Helgstrand E, Johansson NG, Larsson A, Misiorny A, Noren JO, Philipson L, Stenberg K, Stening G, Stridh S, Oberg B (1977) Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob Agents Chemother 11:946\u2013951","journal-title":"Antimicrob Agents Chemother"},{"key":"9224_CR38","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/0042-6822(91)90881-B","volume":"181","author":"LM Scheidel","year":"1991","unstructured":"Scheidel LM, Stollar V (1991) Mutations that confer resistance to mycophenolic acid and ribavirin on Sindbis virus map to the nonstructural protein nsP1. Virology 181:490\u2013499","journal-title":"Virology"},{"key":"9224_CR39","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0168-8278(00)80312-8","volume":"33","author":"SH Fang","year":"2000","unstructured":"Fang SH, Hwang LH, Chen DS, Chiang BL (2000) Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level. J Hepatol 33:791\u2013798","journal-title":"J Hepatol"},{"key":"9224_CR40","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1182\/blood.V97.6.1555","volume":"97","author":"E Zuckerman","year":"2001","unstructured":"Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, Yeshurun D, Rowe JM (2001) The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 97:1555\u20131559","journal-title":"Blood"},{"key":"9224_CR41","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/0006-2952(95)00020-Z","volume":"49","author":"G Di Stefano","year":"1995","unstructured":"Di Stefano G, Busi C, Mattioli A, Fiume L (1995) Selective delivery to the liver of antiviral nucleoside analogs coupled to a high molecular mass lactosaminated poly-L-lysine and administered to mice by intramuscular route. Biochem Pharmacol 49:1769\u20131775","journal-title":"Biochem Pharmacol"},{"key":"9224_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0006-2952(97)00223-2","volume":"54","author":"G Di Stefano","year":"1997","unstructured":"Di Stefano G, Colonna FP, Bongini A, Busi C, Mattioli A, Fiume L (1997) Ribavirin conjugated with lactosaminated poly-L-lysine: selective delivery to the liver and increased antiviral activity in mice with viral hepatitis. Biochem Pharmacol 54:357\u2013363","journal-title":"Biochem Pharmacol"},{"key":"9224_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1006\/abio.1993.1348","volume":"212","author":"L Fiume","year":"1993","unstructured":"Fiume L, Busi G, Di Stefano G, Mattioli A (1993) Coupling of antiviral nucleoside analogues to lactosaminated human albumin by using the imidazolides of their phosphoric esters. Anal Biochem 212:407\u2013411","journal-title":"Anal Biochem"},{"key":"9224_CR44","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1021\/bc0503317","volume":"17","author":"S Brookes","year":"2006","unstructured":"Brookes S, Biessels P, Ng NFL, Woods C, Bell DN, Adamson G (2006) Synthesis and characterization of a hemoglobin-ribavirin conjugate for targeted drug delivery. Bioconjug Chem 17:530\u2013537","journal-title":"Bioconjug Chem"},{"key":"9224_CR45","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/jm00206a005","volume":"21","author":"LB Allen","year":"1978","unstructured":"Allen LB, Boswell KH, Khwaja TA, Meyer RR, Sidwell RW, Witkowski JT (1978) Synthesis and antiviral activity of some phosphates of the broad-spectrum antiviral nucleosides, 1-\u03b2-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Ribavirin). J Med Chem 21:742\u2013746","journal-title":"J Med Chem"},{"key":"9224_CR46","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/hep.21072","volume":"43","author":"GA Levy","year":"2006","unstructured":"Levy GA, Adamson G, James Phillips M, Scrocchi LA, Fung L, Biessels P, Ng NF, Ghanekar A, Rowe A, Ma MX, Levy A, Koscik C, He W, Gorczynski R, Brookes S, Woods C, McGilvray ID, Bell D (2006) Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activity. Hepatology 43:581\u2013591","journal-title":"Hepatology"},{"key":"9224_CR47","first-page":"12","volume":"12","author":"H Wang","year":"1998","unstructured":"Wang H, Zhang L, Wang X (1998) Preliminary clinic observation on the inhibition of HBV by receptor-targeted drug L-HAS-AraAMP. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 12:12\u201314","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"9224_CR48","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/hep.510230401","volume":"23","author":"M Torrani Cerenzia","year":"1996","unstructured":"Torrani Cerenzia M, Fiume L, De Bernardi Venon W, Lavezzo B, Brunetto MR, Ponzetto A, Di Stefano G, Busi C, Mattioli A, Gervasi GB, Bonino F, Ferme G (1996) Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4\u00a0weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects. Hepatology 23:657\u2013661","journal-title":"Hepatology"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11373-007-9224-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11373-007-9224-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11373-007-9224-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11373-007-9224-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T12:15:17Z","timestamp":1630325717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11373-007-9224-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,13]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["9224"],"URL":"https:\/\/doi.org\/10.1007\/s11373-007-9224-9","relation":{},"ISSN":["1021-7770","1423-0127"],"issn-type":[{"value":"1021-7770","type":"print"},{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,13]]}}}